What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Nephro Care India Limited IPO?

Nephro Care India Limited IPO has received a total subscription of 770.15 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Nephro Care India Limited

ListedSME

Healthcare · NSE

Nephro Care India Limited, incorporated in 2014 and based in Kolkata, is a specialized treatment center focusing on renal insufficiency and comprehensive clinical and lifestyle solutions. Supported by expert doctors, paramedical professionals, and a skilled management team, the hospital serves approximately 900 Chronic Kidney Disease patients monthly. Operating from a 5,352 sq. ft. main clinic in Salt Lake and three satellite clinics in Salt Lake (HB 113) and Chandannagar, West Bengal, Nephro Care employs 110 staff members, including 5 permanent doctors, 10 visiting consultants, and 70 paramedical professionals. The center offers a wide range of services, including an in-house Dialysis Unit, outpatient services in nephrology, diabetology, cardiology, ophthalmology, and neurology, an NABL-accredited in-house pathology, a pharmacy, advanced diagnostics, a renal nutrition department, home care, the Mukti Lifestyle Support Program, and home dialysis services.

Price Band

₹85 – ₹90

Issue Size

₹41.26 Cr

Lot Size

1600 shares

GMP

₹175

+194.4%

Est. Listing

₹265

at current GMP

Subscribed

770.15x

overall

Open

28 Jun 2024

2 Jul 2024

Allotment

3 Jul 2024

Refund

4 Jul 2024

Demat Credit

5 Jul 2024

Listing

5 Jul 2024

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

770.15x

Total Demand

QIB Multiplier

245.14x

Institutions & Funds

NII / HNI

1787.56x

High Net-Worth

Retail (RII)

634.12x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 770.15x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	825,600	202,387,200	245.14x
NIB	619,200	1,106,856,000	1787.56x
RETAIL	1,444,800	916,177,600	634.12x
Total	2,889,600	2,225,420,800	770.15x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 675.15x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	1,003	636,022	634.12x
HNIs (10L +)	6	10,725	1787.56x
HNIs (2-10L)	31	55,414	1787.56x
Total Applications	1,040	702,161	675.15x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Nephro Care India Limited Public Issue & Market Profile

Nephro Care India Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹41.26 Crores. The shares are offered at a price band of ₹85 to ₹90 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2024-07-02, the basis of allotment is scheduled to be finalized on 2024-07-03. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Nephro Care India Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Nephro Care India Limited IPO is ₹175 per equity share. Based on the upper price band of ₹85 to ₹90 per equity share, the estimated listing price is ₹265 (+194.4% expected listing gain).

What is the expected profit per lot for Nephro Care India Limited IPO?

With a lot size of 1600 shares and current GMP of ₹175, the expected profit per application lot is approx ₹2,80,000 (+194.4% gain). Minimum application cost is approx ₹1,44,000.

What is the issue size and price band for Nephro Care India Limited IPO?

The Nephro Care India Limited IPO aggregate issue size is ₹41.26 Crores with an equity price band set at ₹85 to ₹90 per equity share. The retail lot size is 1600 shares requiring a minimum capital outlay of approx. ₹1,44,000.

How can I check Nephro Care India Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 770.15x (Retail: 634.12x, QIB: 245.14x, NII: 1787.56x). You can track live multiples directly on our dedicated subscription page.

Where and when will Nephro Care India Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2024-07-03. Investors can verify status using PAN card or application number.

When is the listing date for Nephro Care India Limited IPO?

Nephro Care India Limited shares are scheduled to list on NSE on 2024-07-05.